Early Rhythm Control May Be Cost-Effective in Atrial Fibrillation Care

A cost-effectiveness analysis of the EAST – AFNET 4 trial indicated the health benefits of early rhythm control come at reasonable additional costs compared to usual care.

Related Keywords

Germany ,Hamburg ,Eppendorf ,Nordrhein Westfalen ,Paulus Kirchhof ,University Heart ,Department Of Cardiology ,Vascular Center Hamburg ,Professor Paulus Kirchhof ,Vascular Center ,